Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation
- PMID: 17243048
- DOI: 10.1086/511033
Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation
Abstract
Background: Community-associated (CA) methicillin-resistant Staphylococcus aureus (MRSA) infection has become common worldwide. Some researchers have argued that empirical therapy for MRSA should be given only to patients with suspected CA S. aureus infections who have risk factors for acquisition of MRSA. However, there are no prospective data examining this approach.
Methods: We prospectively enrolled consecutive patients who were hospitalized with S. aureus infection, administered a detailed questionnaire, and collected clinical and microbiological information.
Results: Of the 280 consenting patients, 180 were adults with CA S. aureus infection. Among these subjects, 108 (60%) had MRSA infection, and 78 (40%) had methicillin-susceptible S. aureus (MSSA) infection. MRSA infection was associated with younger age (P<.0001); skin/soft-tissue infection (P=.015); snorting/smoking illegal drugs (P=.01); recent incarceration (P=.03); lower comorbidity index (P=.01); more frequent visits to bars, raves, and/or clubs (P=.03); and higher frequency of laundering clothes in hot water (P=.05). However, the sensitivity, specificity, and predictive values for these factors for discriminating CA-MRSA infection from CA-MSSA infection were relatively poor. Post-hoc modeling revealed that, even in a 10% (i.e., low) MRSA prevalence population, patients lacking the 3 strongest MRSA risk factors would still have a 7% posttest probability of MRSA. Most MRSA strains belonged to the ST-8/USA300 genotype, contained SCCmec type IV, and shared virulence factors commonly found in the ST1:USA400 clone. MSSA strains were genotypically heterogeneous.
Conclusions: We found that clinical and epidemiological risk factors in persons hospitalized for CA S. aureus infection cannot reliably distinguish between MRSA and MSSA. Our findings have important implications for the choice of empirical antibiotic therapy for suspected S. aureus infections and for infection control.
Similar articles
-
The evolution of Staphylococcus aureus.Infect Genet Evol. 2008 Dec;8(6):747-63. doi: 10.1016/j.meegid.2008.07.007. Epub 2008 Jul 29. Infect Genet Evol. 2008. PMID: 18718557 Review.
-
Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.Clin Infect Dis. 2008 Mar 15;46(6):799-806. doi: 10.1086/527389. Clin Infect Dis. 2008. PMID: 18266610
-
A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection.Clin Infect Dis. 2007 Feb 15;44(4):483-92. doi: 10.1086/511041. Epub 2007 Jan 12. Clin Infect Dis. 2007. PMID: 17243049
-
Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.J Infect. 2007 May;54(5):427-34. doi: 10.1016/j.jinf.2006.09.012. Epub 2006 Oct 27. J Infect. 2007. PMID: 17070598
-
The emergence of infections with community-associated methicillin resistant Staphylococcus aureus.J Infect. 2006 Mar;52(3):157-68. doi: 10.1016/j.jinf.2005.09.001. Epub 2005 Nov 9. J Infect. 2006. PMID: 16289303 Review.
Cited by
-
Combining Genome Surveillance and Metadata To Characterize the Diversity of Staphylococcus aureus Circulating in an Italian Hospital over a 9-Year Period.Microbiol Spectr. 2023 Aug 17;11(4):e0101023. doi: 10.1128/spectrum.01010-23. Epub 2023 Jul 17. Microbiol Spectr. 2023. PMID: 37458594 Free PMC article.
-
International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections.Infect Dis Ther. 2022 Dec;11(6):2253-2263. doi: 10.1007/s40121-022-00712-x. Epub 2022 Nov 1. Infect Dis Ther. 2022. PMID: 36319943 Free PMC article.
-
Eleven-Year surveillance of methicillin-resistant Staphylococcus aureus infections at an Academic Health Centre.J Prev Med Hyg. 2022 Apr 26;63(1):E132-E138. doi: 10.15167/2421-4248/jpmh2022.63.1.2387. eCollection 2022 Mar. J Prev Med Hyg. 2022. PMID: 35647383 Free PMC article.
-
Predictive Role of Targeted, Active Surveillance Cultures for Detection of Methicillin-Resistant Staphylococcus aureus.Infect Drug Resist. 2021 Nov 12;14:4757-4764. doi: 10.2147/IDR.S340871. eCollection 2021. Infect Drug Resist. 2021. PMID: 34795491 Free PMC article.
-
Higher Risk for All-cause Mortality of Staphylococcus aureus Bacteremia in Patients with Non-Dialysis Dependent Chronic Kidney Disease.Infect Chemother. 2020 Mar;52(1):82-92. doi: 10.3947/ic.2020.52.1.82. Epub 2020 Feb 20. Infect Chemother. 2020. PMID: 32114722 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical